{"id":17206,"date":"2013-10-25T04:30:00","date_gmt":"2013-10-25T02:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/ricerca-in-italia-myrmex-e-i-soliti-amici-a-volte-ritornano\/"},"modified":"2013-10-25T04:30:00","modified_gmt":"2013-10-25T02:30:00","slug":"ricerca-in-italia-myrmex-e-i-soliti-amici-a-volte-ritornano","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/ricerca-in-italia-myrmex-e-i-soliti-amici-a-volte-ritornano\/","title":{"rendered":"Search in Italy? Myrmex and the usual friends. Sometimes they come back."},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">&nbsp;<img decoding=\"async\" title=\"\" alt=\"\" src=\"http:\/\/www.ansa.it\/webimages\/section_210\/2012\/9\/17\/e14cd4e7b97b7651b224b71da0abc51d.jpg\" \/>&nbsp; February 22, 3.41pm<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-size: 12pt\"><font face=\"Calibri\">(ANSA) - MILAN, FEBRUARY 22 - 2012 was a difficult year for the non-prescription drug sector: the data in fact indicate a drop in consumption of 5.4% and a contraction in expenditure of 3.7%. This was announced by ANIFA, the national association of manufacturers of self-medication drugs.<\/p>\n<p> However, thanks to the &#039;delisting&#039; of over 350 packs of medicines, the non-prescription market is holding up with a more contained decrease in consumption (-1.6%) and an increase in turnover (+2.5%) compared to 2011.<\/font><\/span><span style=\"line-height: 115%; font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; font-size: 12pt\"><\/p>\n<p><\/span><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp;&nbsp; 22 febbraio, 15:41 (ANSA) &#8211; MILANO, 22 FEB &#8211; Il 2012 e&#8217; stato un anno difficile per il comparto dei farmaci senza obbligo di ricetta: i dati indicano infatti un calo dei consumi del 5,4% e una contrazione della spesa del 3,7%. Lo rende noto Anifa, l&#8217;associazione nazionale dei produttori di farmaci da automedicazione. &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17206","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17206"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17206\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}